John Henderson
Chairman bij CYTOKINETICS, INCORPORATED
Vermogen: 3 M $ op 29-02-2024
Profiel
Currently, John Tannahill Henderson is Chairman of Cytokinetics, Inc.
In his past career he occupied the position of Independent Director at Myriad Genetics, Inc., President at Futurepharm LLC, VP-Europe, US & International Pharmaceuticals at Pfizer Inc. and Vice President at Pfizer Pharmaceuticals, Inc. (a subsidiary of Pfizer Inc.), Chief Development Officer for NeuroVia, Inc. and Chairman of Asmacure Ltée.
Dr. Henderson received a doctorate and an undergraduate degree from The University of Edinburgh.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
14-02-2024 | 42 715 ( 0.04% ) | 3 M $ | 29-02-2024 |
Actieve functies van John Henderson
Bedrijven | Functie | Begin |
---|---|---|
CYTOKINETICS, INCORPORATED | Chairman | 08-04-2022 |
Eerdere bekende functies van John Henderson
Bedrijven | Functie | Einde |
---|---|---|
MYRIAD GENETICS, INC. | Chairman | 23-03-2020 |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-10-2018 |
MYREXIS, INC. | Director/Board Member | 01-01-2013 |
PFIZER, INC. | Corporate Officer/Principal | 01-12-2010 |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01-12-2000 |
Opleiding van John Henderson
The University of Edinburgh | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
PFIZER, INC. | Health Technology |
MYRIAD GENETICS, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
MYREXIS, INC. | Finance |
Bedrijven in privébezit | 5 |
---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |